A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study. Article uri icon

Overview

publication date

  • January 19, 2020

Research

keywords

  • Multiple Myeloma

Identity

PubMed Central ID

  • PMC7580780

Scopus Document Identifier

  • 85078222429

Digital Object Identifier (DOI)

  • 10.1080/10428194.2019.1672058

PubMed ID

  • 31957517

Additional Document Info

volume

  • 61

issue

  • 2